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Lo´pez-Herna´ndez et al., page 422
Leukodystrophy refers to a lack of growth of the white
matter of the brain, which is primarily composed of
myelinated axons. Several diseases and syndromes are
characterized by leukodystrophy. These are caused by
genetic mutations in genes involved in the production or
metabolism ofmyelin. Inheritancemay be recessive, domi-
nant, or X-linked. One such disorder, megalencephalic
leukoencephalopathy with subcortical cysts (MLC), is
characterized by early-onset macrocephaly (enlargement
of the head) and neurological deterioration. Although
MLC1 mutations are responsible for the majority of cases
of this autosomal-recessive condition, not all people with
MLC harbor MLC1 mutations. Interestingly, the exact
role of MLC1 has remained elusive. In an attempt to iden-
tify MLC-causative mutations in genes other than MLC1,
Lo´pez-Herna´ndez and colleagues set out to find proteins
that interact with MLC1 and work backward from there.
Using affinity chromatography and mass spectrometry,
these authors identify GlialCAM as a prominent MLC1-
interacting protein in the brain. Sequence analysis of
HEPACAM (which encodes GlialCAM) reveals a number
of missense mutations in different familial and isolated
cases of MLC. Some mutations are found to be recessive
and others dominant. Remarkably, all cases harboring
only one HEPACAM mutation show an improvement in
phenotype over time. This study expands both the spec-
trum of the MLC phenotype and the number of genes
harboring causative mutations. Although the biological
role of GlialCAM still remains to be discovered, this work
highlights the utility of biochemistry in genetic studies.What the Condel Is Going On with This Variant?
Gonza´lez-Pe´rez and Lopez-Bigas, page 440
The need to determine whether a variant is pathogenic or
neutral has been a focus of geneticists who have identified
a variant of unknown significance during a clinical screen
or during a search to find which gene is mutated in
a disease. As sequencing technology has become more
cost-efficient, the number of variants identified has
increased dramatically, and methods to establish whether
a variant is deleterious or not are growing in importance.
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affected and the functional impacts of certain modifica-
tions on predicting whether the variant would be well
tolerated by the protein. Eachmethod performs a bit differ-
ently from the others, has been tested on different data
sets, and provides information that isn’t always compa-
rable. So, what is the best way to use these tools to comple-
ment each other? In this issue, Gonzalez-Perez and Lopez-
Bigas present their work to integrate the output of several
of these predictive tools. The authors establish the best
means of combining the methods, and the resulting
deleteriousness score of missense mutations is called the
Condel. They find that the Condel more accurately
predicts the impact of the mutation than do each of the
methods separately. Importantly, although the authors
selected five specific methods to combine in Condel for
this work, the protocol is flexible and can be easily modi-
fied to integrate new methods into the analysis.Characterizing Chromosomal Rearrangements
with Sequencing
Talkowski et al., page 469
The ability of high-throughput sequencing technologies to
identify nucleotide variants has revolutionized disease-
mutation identification, and here Talkowski and
colleagues demonstrate that such technologies can also
be used to characterize balanced chromosomal rearrange-
ments in a fast and cost-effective manner. Traditional
means of establishing the sites of chromosomal disruption
have involved karyotyping and FISH followed by more
precise mapping with targeted Southern blot analysis and
PCR. In some cases microarrays have simplified some of
these steps, but if the rearrangement is balanced, microar-
rays may not be useful. The authors provide details of and
resources for their high-throughput library preparations,
sequencing procedures, and bioinformatic analyses and
utilize their strategies to evaluate the breakpoints in
individuals with apparently balanced chromosomal
rearrangements. During the time of the study, technolog-
ical advancements were implemented, and the authors
also provide a cost analysis of the different methods
used. A more targeted and less expensive approach is
used on cases in which the breakpoints had already been
significantly fine mapped. In most of the cases, Talkowski
and colleagues are able to determine the sequence of theGenetics. All rights reserved.
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rearrangement breakpoints at base-pair resolution and also
to discover unexpected complexity. In addition, the
authors developed a web-based tool that can predict how
many bases of sequence are needed in a particular region
to ensure that the sequence will be uniquely aligned to
the reference sequence. This Genome Mappability
Surveyor, which excludes significantly less of the genome
than does RepeatMasker, will be a useful tool for investiga-
tors who hope to use these strategies to characterize the
chromosomal rearrangements in their own samples.Skin Deep
Israeli et al., page 482
A soft kiss, a warm embrace, a strong handshake: These
actions are all conveyed via skin. In addition to transmit-
ting sensations, skin functions as a barrier to protect our
bodies from the external environment. It also helps us to
regulate heat and maintain proper moisture. Damage to
the skin, whether the result of genetic or environmental
causes, puts us at risk. Genetic skin disorders, referred to
as congenital ichthyoses, appear in several forms and
severities, presenting different levels of risk. Fortunately,
the most common type of congenital ichthyosis is also
the most moderate: ichthyosis vulgaris; an autosomal-
dominant condition. Rarer are the autosomal-recessive
congenital ichthyoses (ARCI). At least six different genes
have been found to be mutated in ARCIs, but around
20% of all reported cases still lack a definitive genetic attri-
bution. ARCIs are primarily diagnosed by either looking at
the skin or evaluating a skin biopsy. Lipid metabolism has
been shown to be altered in many different forms of
ichthyosis, and genes encoding proteins in the lipid or
lipid-related pathways have been shown to be mutated in
these conditions. In this issue, Israeli and colleagues use
homozygosity mapping and candidate-gene sequencing398 The American Journal of Human Genetics 88, 397–398, April 8, 2to identify causative LIPN mutations in a large family
with ARCI. LIPN encodes Lipase N, a lipase of unknown
function found in the epidermis. This study adds another
gene to the growing list of those important for the develop-
ment and maintenance of our largest organ, the skin.Don’t Count Your Eggs by Counting Your Polar
Bodies
Gigarel et al., page 494
Preimplantation genetic diagnosis (PGD) and preconcep-
tion diagnosis (PCD) are services that have been very
useful to couples who have a mutation that they don’t
want to pass along to their children. The processes involve
performing genetic diagnostics on a cell removed from
a developing embryo, in the case of PGD, or from a polar
body as a proxy for an unfertilized oocyte, in the case of
PCD. Those embryos and oocytes that are found to be
mutation-free are then used for implantation or in vitro
fertilization, respectively. In this issue, Gigarel and
colleagues report that there may be problems associated
with looking at the polar bodies when trying to assess
the mutant load of mitochondrial DNA mutations. The
polar bodies divide from the oocyte when the egg
develops, and it has been assumed that the mutant load
of the polar bodies matches that of the oocyte. This
assumption is supported by mouse data, but here the
authors demonstrate that this is not the case for human
mitochondrial mutations. They compare the mitochon-
drial mutant load of polar bodies with that of the corre-
sponding oocyte, blastomere or embryo from women
with three different mitochondrial mutations. They find
that there is a poor correlation between the mutant loads
of polar bodies and their counterparts and that using the
polar bodies as proxies could lead to incorrect conclusions
regarding which eggs or embryos are disease-free.011
